Contravisory Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Contravisory Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.33M	Buy	+10,147	New	+$6.91M	1.12%	38
2023 Q3	–	Sell	-473	Closed	-$340K	–	376
2023 Q2	$340K	Buy	+473	New	+$365K	0.09%	158
2018 Q3	–	Sell	-14	Closed	-$5K	–	357
2018 Q2	$5K	Hold	14	–	–	﹤0.01%	295
2018 Q1	$5K	Buy	+14	New	+$4.87K	﹤0.01%	298
2016 Q1	–	Sell	-4	Closed	-$2K	–	225
2015 Q4	$2K	Buy	+4	New	+$2.17K	﹤0.01%	186

Other funds holding REGN

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Jacobs & Co San Francisco, California $1.17B AUM 37.3% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return